OLMA
Olema Pharmaceuticals Inc
NASDAQ: OLMA · HEALTHCARE · BIOTECHNOLOGY
$14.41
+1.91% today
Updated 2026-04-30
Market cap
$1.23B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.87
Dividend yield
—
52W range
$4 – $36
Volume
1.6M
Olema Pharmaceuticals Inc (OLMA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-36.60%
ROA
-21.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-2.20M | — | — | — |
| 2019 | $0.00 | $-4.32M | — | — | — |
| 2020 | $0.00 | $-22.12M | — | — | — |
| 2021 | $0.00 | $-71.10M | — | — | — |
| 2022 | $0.00 | $-102.59M | — | — | — |
| 2023 | $0.00 | $-96.66M | — | — | — |
| 2024 | $0.00 | $-129.47M | — | — | — |
| 2025 | $0.00 | $-162.45M | — | — | — |